(Q45898127)

17 December 2017

title

Current Lynch syndrome tumor screening practices: a survey of genetic counselors. (English)

1 reference

17 December 2017

1 reference

Stephanie A Cohen

1

1 reference

17 December 2017

publication date

15 May 2013

1 reference

17 December 2017

Journal of Genetic Counseling

published in

1 reference

17 December 2017

volume

23

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

38-47

1 reference

17 December 2017

Risks of Lynch syndrome cancers for MSH6 mutation carriers

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Colorectal cancer due to deficiency in DNA mismatch repair function: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Strategies for identifying hereditary nonpolyposis colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Feasibility of screening for Lynch syndrome among patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

The role of genetic testing for cancer susceptibility in gynecologic practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Testing women with endometrial cancer to detect Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Hereditary nonpolyposis colorectal cancer (HNPCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Clinical implications of microsatellite instability in sporadic colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Informed consent and immunohistochemistry screening for Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Ten Years After Mutation Testing for Lynch Syndrome: Cancer Incidence and Outcome in Mutation-Positive and Mutation-Negative Family Members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Low frequency ofBRAFandCDKN2Amutations in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Informed consent to microsatellite instability and immunohistochemistry screening for Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

To Screen or Not To Screen for Lynch Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9603-5

Lynch syndrome screening implementation: business analysis by a healthcare system.

21 January 2018

1 reference

12 December 2020

Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer

1 reference

12 December 2020

Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients

1 reference

12 December 2020

Genetic instability of microsatellites in endometrial carcinoma

1 reference

12 December 2020

Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.

1 reference

12 December 2020

Endometrial cancer patients and compliance with genetic counseling: room for improvement.

1 reference

12 December 2020

Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability

1 reference

12 December 2020

Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome

1 reference

12 December 2020

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

1 reference

12 December 2020

Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer

1 reference

12 December 2020

Microsatellite instability in endometrial carcinoma

1 reference

12 December 2020

Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II)

1 reference

12 December 2020

10.1007/S10897-013-9603-5

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017